Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Reading disorder
ADR ID BADD_A07631
ADR Hierarchy
19      Psychiatric disorders
19.21      Cognitive and attention disorders and disturbances
19.21.05      Learning disorders
19.21.05.003      Reading disorder
Description A cognitive disorder characterized by an impaired ability to comprehend written and printed words or phrases despite intact vision. This condition may be developmental or acquired. Developmental dyslexia is marked by reading achievement that falls substantially below that expected given the individual's chronological age, measured intelligence, and age-appropriate education. The disturbance in reading significantly interferes with academic achievement or with activities of daily living that require reading skills. (From DSM-IV) [MeSH]
MedDRA Code 10037999
MeSH ID D004410
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Developmental reading disorder | Developmental reading disorder, unspecified | Other specific developmental reading disorder | Reading disorder | Specific reading retardation | Dyslexia | Dyslexias | Word Blindness | Blindness, Word | Blindnesses, Word | Word Blindnesses | Reading Disorder | Disorder, Reading | Disorders, Reading | Reading Disorders | Reading Disorder, Developmental | Developmental Reading Disorders | Disorder, Developmental Reading | Disorders, Developmental Reading | Reading Disorders, Developmental | Developmental Reading Disorder | Dyslexia, Developmental | Developmental Dyslexia | Developmental Dyslexias | Dyslexias, Developmental | Reading Disability, Developmental | Developmental Reading Disabilities | Developmental Reading Disability | Disabilities, Developmental Reading | Disability, Developmental Reading | Reading Disabilities, Developmental | Alexia | Alexias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00115Amiodarone0.000404%
BADD_D00165Aripiprazole0.000079%
BADD_D00356Carbamazepine0.000186%
BADD_D00898Finasteride0.000067%
BADD_D00932Fluoxetine0.000020%
BADD_D01285Levothyroxine0.000005%
BADD_D01290Lifitegrast0.001362%
BADD_D01645Oxycodone0.000021%
BADD_D01654Palbociclib0.000381%
BADD_D01765Phenytoin0.000191%
BADD_D01835Pregabalin0.000622%
BADD_D02010Sertraline0.000013%
BADD_D02236Tofacitinib0.000530%
BADD_D02329Valproic acid0.000549%
BADD_D02464Fingolimod0.000482%
BADD_D02470Nintedanib0.000246%
BADD_D02504Lorlatinib0.000246%
The 1th Page    1    Total 1 Pages